European Parliament report on Europe’s Beating Cancer Plan
Recent discussions in the European Parliament on the implementation of Europe's Beating Cancer Plan have highlighted the…
Read more
EU Horizon Europe - EU Mission on Cancer - Coordination and Support Action (CSA)
Boosting translation in cancer research
TRANSCAN-4 coordinates national and regional funding organisations to support high-impact translational cancer research.
28 Partners
17 Countries
2 Associated partners
Featured call
Joint Call JTC 2026
Translational Research on Cancer Metabolism: Multidisciplinary Approaches for Diagnosis and Treatment
TRANSCAN
Partners network
Funding organisations
A transnational network for cancer research
TRANSCAN brings together national and regional organisations supporting translational cancer research across Europe and beyond.
28
Funding organisations
17
Countries
International coverage
The figures shown here are calculated from the TRANSCAN-4 partners linked to phase 4 in the website database.
Partner organisations
TRANSCAN participating entities.
Latest News
Updates about calls, events and project milestones.
Success Stories
Impact highlights from funded projects.
An interview with ECR, Dr. Pinar Pir
An interview with young Principal Investigator Dr. Pinar Pir, partner in the iParaCyts project funded under TRANSCAN-3 JTC 2021.
Meet ECR, Dr. Sheng-Fang Su
Meet Dr. Sheng-Fang Su, an early-career researcher involved in the BeFIT project.
Programme phases
From TRANSCAN to TRANSCAN-4: a long-term European effort in translational cancer research.
TRANSCAN-4
2026–2031
Active
TRANSCAN-4
European Network for Translational Cancer Research
<p>Current phase of the TRANSCAN initiative supporting collaborative cancer research.</p>
17
Countries
30
Partners
1
Calls
€5.8M
EU contribution
Funded Research Output
Catalogue of funded projects, participating countries and funders.
Browse the catalogue of projects funded through TRANSCAN joint transnational calls.
141
Funded projects
JTC 2024
JTC 2023
JTC 2022
JTC 2021
JTC 2017
JTC 2016
Latest funded projects
ACCELERATE
JTC 2024 · Functional precision medicine platform for the treatment of pancreatic cancer
›
BePrepared
JTC 2024 · Building an ex vivo complex tumour microenvironment platform for development of combination therapies and drug resistance studies in head neck cancer
›
DOPPLER-LC
JTC 2024 · Development Of Patient-derived organoid PLatform for Evading Resistances in Lung Cancer
›
Partner portal
Area for partners, documents and collaboration.